References:
1. Allana SS, Kostantinis S, Rempakos A, Simsek B, Karacsonyi J,
Alexandrou M, Choi JW, Alaswad K, Krestyaninov O, Khelimskii D, Gorgulu
S, Davies R, Benton S, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit
P, Azzalini L, Kearney K, Chandwaney R, Nicholson W, Jaber W, Rinfret S,
Frizzell J, Patel T, Jefferson B, Aygul N, Rangan BV, Brilakis ES. The
Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary
Interventions: Technical Analysis and Procedural Outcomes. JACC
Cardiovasc Interv. 2023 Nov 27;16(22):2748-2762.1.
2. Boden WE, O’Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada
M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR,
Mancini GB, Weintraub WS; COURAGE Trial Investigators Impact of optimal
medical therapy with or without Percutaneous coronary intervention on
long-term cardiovascular end points in patients with stable coronary
artery disease (from the COURAGE Trial). Am J Cardiol. 2009
:1;104(1):1-4.
3. Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R,
Hueb W, Hardison RM, Abbott JD, Brown DL. Percutaneous coronary
intervention outcomes in patients with stable obstructive coronary
artery disease and myocardial ischemia: a collaborative meta-analysis of
contemporary randomized clinical trials. JAMA Intern Med. 2014 Feb
1;174(2):232-40
4. Kim MH, Mitsudo K, Jin CD, Kim TH, Cho YR, Park JS, Park K, Park TH,
Serebruany V. Long-term clinical outcomes after successful and failed
recanalization to native chronic Total occlusion: Insights from the
Busan chronic Total occlusion (B-CTO) Registry. Cardiovasc Revasc Med.
2016 Jun;17(4):229-32.
5. Nathan, Allistair et al. “Percutaneous Coronary Intervention of
Chronic Total Occlusion Associated with Higher Inpatient Mortality and
Complications Compared With Non-CTO Lesions.” The American journal of
medicine vol. 136,10 (2023): 994-999.
6. Movahed MR. Significant Downplay and Underreporting of Adverse Events
in Patients Who Underwent Percutaneous Coronary Intervention of Chronic
Total Occlusions. Am J Cardiol. 2023, 210;317
7. Movahed MR. It is time to have better oversite and accountability in
performing too many not indicated percutaneous coronary interventions in
patients with chronic total occlusions. Int J Cardiol. 2019 Mar
1;278:38-39.